Second-line treatment options: the COH experience with bispecific antibodies for AL amyloidosis

Webinar Session: Wednesday, July 15th at 6 PM (ET) Zoom Meeting

(These sessions will not be recorded due to patient involvement and HIPAA laws)

To Register HERE

Second-line treatment options: the COH experience with bispecific antibodies for AL amyloidosis

Join us for a session on second-line treatment options for AL amyloidosis, focusing on City of Hope’s experience with bispecific antibodies. Experts will explain how these therapies work, where they may fit when other treatments fall short, and what patients may expect. Hear insights, patient perspectives, and guidance for your treatment journey.

Sarah Lee, M.D., has always been drawn to medicine by a deep desire to care for others. As a hematologist-oncologist at City of Hope®️ Cancer Center Duarte, Dr. Lee helps diagnose and treat blood disorders, with particular expertise in multiple myeloma. She is dedicated to a thoughtful, patient-centered approach to cancer care, making it a priority to understand each patient’s goals and help guide them through their care with clarity and compassion.